SMTL ID : 2og8.1 (1 other biounit)

crystal structure of aminoquinazoline 36 bound to Lck

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x 1N8: N-{2-[(N,N-DIETHYLGLYCYL)AMINO]-5-(TRIFLUOROMETHYL)PHENYL}-4-METHYL-3-[2-(METHYLAMINO)QUINAZOLIN-6-YL]BENZAMIDE(Non-covalent)

1N8.1: 21 residues within 4Å: Chain A: V.24, A.36, V.37, K.38, E.53, M.57, L.60, L.65, V.66, I.79, T.81, E.82, Y.83, M.84, G.87, Y.125, L.136, I.145, A.146, D.147, F.148 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:V.24, A:A.36, A:K.38, A:T.81, A:L.136, A:D.147, A:F.148, A:F.148 Hydrogen bonds: A:E.53, A:M.84, A:M.84, A:D.147, A:D.147 Salt bridges: A:E.53, A:D.147 pi-Cation interactions: A:K.38

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

DiMauro, E.F. et al., Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity. J.Med.Chem. (2006)

Release Date

2007-02-27

Peptides

Proto-oncogene tyrosine-protein kinase LCK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase LCK

Related Entries With Identical Sequence